Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument
The Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP, with the ticker GB:SLLY, is a specialized investment product designed for those interested in the pharmaceuticals niche within the broader health care sector. This Exchange Traded Product (ETP) aims to deliver -3 times the daily performance of Eli Lilly and Company's equity, after accounting for fees and expenses. This means that for every 1% decline in Eli Lilly's stock price, the ETP is structured to potentially increase by 3%, serving as a powerful tool for investors looking to capitalize on short-term downward movements in Eli Lilly's stock. Ideal for sophisticated traders with a strong risk tolerance, this inverse ETP offers a strategic opportunity to engage in short-selling within the pharmaceutical industry, leveraging market volatility and sector-specific dynamics. As such, it caters to investors with a keen interest in strategic, short-term trading, and those who wish to hedge their exposure in the health care sector.
Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument (SLLY) Fund Flow Chart
Leverage Shares Public Limited Company LS -3X SHORT ELI LILLY ETP 2025-21.07.75 on Structured Instrument (SLLY) 1 year Net Flows: 0
SLLY ETF FAQ
What was GB:SLLY’s price range in the past 12 months?
GB:SLLY lowest ETF price was 698.13 and its highest was 842.75 in the past 12 months.
What is the AUM of GB:SLLY?
As of Nov 06, 2025 The AUM of GB:SLLY is 48.04K.
Is GB:SLLY overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does GB:SLLY pay dividends?
GB:SLLY does not currently pay dividends.
How many shares outstanding does GB:SLLY have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:SLLY?
Currently, no hedge funds are holding shares in GB:SLLY